Healthness v. Empatica: Remote Monitoring Patent Suit Dismissed With Prejudice
Healthness LLC sued Empatica Inc. in Delaware District Court alleging infringement of two patents covering systems and methods for remotely monitoring movement of individuals. The parties jointly stipulated to dismiss all claims with prejudice under Rule 41(a)(1)(A)(ii), with each side bearing its own costs — ending the dispute 279 days after filing.
Remote monitoring patent claims end in mutual walk-away
Healthness LLC filed suit against Empatica Inc. on 7 March 2025 in the United States District Court for the District of Delaware, asserting infringement of US6445298B1 and US6696957B2. Both patents relate to systems and methods for remotely monitoring the movement of individuals — a technology category directly relevant to Empatica’s wearable health-monitoring product line. The case was assigned to Judge John Campbell Barker.
The case closed on 11 December 2025 via a joint stipulation of dismissal with prejudice pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(ii). The dismissal is with prejudice, meaning Healthness is permanently barred from asserting the same claims against Empatica in future litigation. Critically, the stipulation specifies that each party bears its own costs, expenses, and attorneys’ fees — a symmetrical resolution that neither party can characterise as a financial victory.
The 279-day timeline from filing to dismissal suggests the matter resolved before substantial discovery or claim construction proceedings concluded, which is consistent with a negotiated settlement or licensing arrangement reached informally. The public record does not disclose whether any licensing agreement, payment, or product design change accompanied the dismissal — leaving the commercial terms, if any, entirely undisclosed.
Filing to Case Dismissed in 279 days
279 days — resolved before trial, faster than the Delaware District Court median for patent cases
Dismissed with prejudice: what the stipulation means for both parties
Rule 41(a)(1)(A)(ii) dismissal with prejudice explained
A stipulated dismissal under Rule 41(a)(1)(A)(ii) requires the consent of all parties who have appeared and filed. The ‘with prejudice’ designation is the critical modifier: unlike a without-prejudice dismissal, it operates as a final adjudication on the merits, permanently extinguishing Healthness’s right to sue Empatica on the same patents and claims. The court need not approve such a stipulation — it takes effect upon filing.
Final and permanent dismissalHealthness permanently forfeits these claims against Empatica
By agreeing to dismissal with prejudice, Healthness LLC surrenders any future right to assert US6445298B1 or US6696957B2 against Empatica for the accused products and conduct. This is a significant litigation concession. However, Healthness retains the right to enforce both patents against third parties. The absence of a fee award suggests neither party achieved a clear-cut legal victory prior to settlement.
No re-filing against EmpaticaEmpatica secures permanent immunity from these specific patent claims
Empatica Inc. emerges with a binding guarantee that Healthness cannot revive these particular infringement claims. The mutual cost-bearing arrangement means Empatica absorbed its own legal fees without recovery — consistent with a negotiated resolution rather than a court-ordered defendant win. Empatica’s retained counsel at Fish & Richardson typically signals a robust defence strategy, which may have influenced Healthness’s decision to stipulate.
Claim-proof against HealthnessWearable monitoring sector: patent risk remains for other players
The dismissal resolves risk for Empatica specifically, but US6445298B1 and US6696957B2 remain active and enforceable against the broader market. Other wearable health monitoring and remote patient tracking companies that incorporate movement-detection or individual monitoring functionality should treat these patents as live enforcement risk. The case’s swift resolution may signal Healthness is actively licensing rather than pursuing full trial.
Patents remain enforceableFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Healthness, LLC | Company | Remote monitoring IP licensing entity — holder of US6445298B1 and US6696957B2Search in Eureka ↗ |
| Defendant | Empatica, Inc. | Company | Empatica Inc. — wearable biosensor and health monitoring device developerSearch in Eureka ↗ |
| Plaintiff counsel | Antranig N. Garibian | Attorney | Counsel for Healthness, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Garibian Law Offices, PC | Law Firm | Representing Healthness, LLCSearch in Eureka ↗ |
| Defendant counsel | Michael A. Amon | Attorney | Counsel for Empatica, Inc.Search in Eureka ↗ |
| Defendant counsel | Taylor Reeves | Attorney | Counsel for Empatica, Inc.Search in Eureka ↗ |
| Defendant law firm | Fish & Richardsin PC | Law Firm | Representing Empatica, Inc.Search in Eureka ↗ |
| Presiding judge | Judge John Campbell Barker | Judge | Delaware District CourtSearch in Eureka ↗ |
Official order — verbatim text
The stipulation’s language — ‘each party shall bear its own costs, expenses, and attorneys’ fees’ — is a deliberate symmetry that forecloses any inference of winner or loser from the public record. The with-prejudice designation is substantively significant: it has the legal effect of a merits judgment, permanently barring Healthness from relitigating these claims against Empatica. No invalidity findings, no claim construction rulings, and no infringement conclusions are embedded in the record.
US6445298B1 & US6696957B2 — Remote Individual Movement Monitoring
US6445298B1 (App. No. 09/746394) and US6696957B2 (App. No. 10/156254) both cover systems and methods for remotely monitoring the movement of individuals. With application dates in the early 2000s, these patents were filed during the early commercial emergence of wireless telemetry and GPS-based tracking — well before the modern wearable health device market matured. Their claims likely encompass core architectural approaches to remote sensing, data transmission, and alerting for individual movement.
For today’s wearable biosensor and remote patient monitoring market, patents with early-2000s priority in individual movement tracking carry significant strategic weight. Empatica’s Embrace and EmbracePlus devices — worn on the wrist and designed to detect physiological events including movement — sit squarely in the technology space these patents address. Any company commercialising wearable activity monitoring, fall detection, elder care tracking, or remote patient surveillance should assess exposure to these claims before scaling deployment.
Should your product team run an FTO against US6445298B1 and US6696957B2?
If your organisation develops or deploys wearable health monitors, remote patient tracking systems, elder care safety devices, or any connected health product that transmits individual movement data, these two patents warrant a formal freedom-to-operate analysis. The Healthness v. Empatica filing demonstrates that the patent holder is actively enforcing — and targeting commercially relevant wearable device companies specifically.
PatSnap Eureka’s FTO Search Agent can map the independent claims of US6445298B1 and US6696957B2 against your product architecture, flag prior art that could support invalidity arguments, and surface design-around options. Given the early priority dates, Eureka can also identify the closest prior art from late-1990s telemetry and GPS tracking literature — critical input for any inter partes review or litigation defence strategy.
Run a freedom-to-operate analysis on US6445298B1 to assess your product’s exposure
Run FTO in Eureka →Similar remote monitoring patent cases in Delaware District Court
Explore related patent infringement actions involving remote health monitoring and wearable movement tracking technology litigated in the Delaware District Court.
What this case signals for the wearable health monitoring IP landscape
A with-prejudice stipulation in a Delaware patent case this early typically reflects a negotiated commercial resolution — not an abandonment of IP strategy.
Early dismissal patterns in Delaware often mask private licensing deals
Cases dismissed by joint stipulation before claim construction — with each party bearing its own fees — are frequently the visible tip of a confidential licence or covenant-not-to-sue. Competitors in the remote monitoring space should assume Healthness has an active licensing programme rather than interpreting this dismissal as a weakening of its patent portfolio.
US6445298B1 and US6696957B2 remain fully enforceable against the market
The dismissal with prejudice applies only to Empatica. Both asserted patents survive intact and can be enforced against any other company whose products fall within the claims covering remote individual movement monitoring. Companies in wearables, remote patient monitoring, elder care tech, and connected health should run FTO searches against these patents before product launch.
Healthness v Empatica — key questions answered
Healthness LLC sued Empatica Inc. in Delaware District Court on 7 March 2025 asserting infringement of US6445298B1 and US6696957B2. The case was dismissed with prejudice by joint stipulation on 11 December 2025, with each party bearing its own costs. No court ruling on validity or infringement was issued.
Both patents cover systems and methods for remotely monitoring the movement of individuals. Filed in the early 2000s, they address core remote telemetry and tracking architectures. They remain enforceable against third parties following the Empatica dismissal and are relevant to wearable health monitoring, remote patient tracking, and connected care products.
Dismissal with prejudice under Rule 41(a)(1)(A)(ii) permanently extinguishes Healthness’s right to sue Empatica on the same patents and accused conduct. It has the legal effect of a final judgment. However, Healthness retains full rights to enforce the patents against other third parties. Empatica is effectively immunised from these specific claims.
No. The stipulated dismissal contains no invalidity findings, no claim construction rulings, and no infringement determinations. US6445298B1 and US6696957B2 remain presumed valid and fully enforceable. Companies other than Empatica remain exposed to potential infringement assertions from Healthness.
Healthness LLC was represented by Antranig N. Garibian of Garibian Law Offices PC. Empatica Inc. was represented by Michael A. Amon and Taylor Reeves of Fish & Richardson PC — one of the leading patent litigation firms in the United States, known for aggressive defence strategies in Delaware patent cases.
PatSnap Eureka searches patents and litigation data to answer instantly.